This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Simon Nicolle: Inventor of mTOR Kinase Inhibitor Compounds
Introduction
Simon Nicolle is an inventor associated with Stevenage, Great Britain. His recorded patent work includes a pharmaceutical invention concerning compounds with mTOR kinase inhibitor activity.
Latest Patents
Nicolle is associated with 1 patent, titled “Chemical compounds.” The invention describes compounds of formula (I), or pharmaceutically acceptable salts, with mTOR kinase inhibitor activity. It also covers pharmaceutical compositions containing these compounds and their therapeutic use, including for diseases or conditions where mTOR inhibition may be beneficial, particularly idiopathic pulmonary fibrosis.
Career Highlights
Nicolle is associated with GlaxoSmithKline Intellectual Property Development Limited. His patent work reflects research into potential therapeutic compounds and their pharmaceutical applications.
Collaborations
His listed coworkers include Heather Hobbs and Graham George Adam Inglis.
Conclusion
Simon Nicolle’s recorded invention focuses on mTOR kinase inhibitor compounds and their potential use in treating conditions such as idiopathic pulmonary fibrosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile